Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 6 studies | 24% ± 6% | |
adipocyte | 6 studies | 27% ± 8% | |
hepatocyte | 5 studies | 71% ± 23% | |
adventitial cell | 5 studies | 26% ± 6% | |
mesothelial cell | 4 studies | 46% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 58640.38 | 226 / 226 | 95% | 338.07 | 387 / 406 |
prostate | 87% | 4517.11 | 214 / 245 | 85% | 13.11 | 427 / 502 |
kidney | 89% | 7788.49 | 79 / 89 | 82% | 43.19 | 737 / 901 |
pancreas | 98% | 11807.22 | 323 / 328 | 69% | 11.06 | 122 / 178 |
adrenal gland | 100% | 66840.55 | 258 / 258 | 66% | 52.02 | 152 / 230 |
breast | 95% | 12813.56 | 438 / 459 | 57% | 7.85 | 640 / 1118 |
ovary | 100% | 8598.33 | 180 / 180 | 29% | 2.53 | 124 / 430 |
lung | 84% | 4944.91 | 484 / 578 | 42% | 4.46 | 481 / 1155 |
thymus | 80% | 4651.07 | 523 / 653 | 32% | 5.14 | 196 / 605 |
skin | 78% | 9291.98 | 1420 / 1809 | 27% | 2.62 | 126 / 472 |
bladder | 86% | 9773.81 | 18 / 21 | 16% | 1.25 | 79 / 504 |
adipose | 100% | 18617.29 | 1201 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 64% | 3967.70 | 918 / 1445 | 24% | 2.56 | 44 / 183 |
blood vessel | 85% | 6943.94 | 1129 / 1335 | 0% | 0 | 0 / 0 |
uterus | 60% | 3023.46 | 102 / 170 | 19% | 1.92 | 88 / 459 |
intestine | 55% | 2619.31 | 528 / 966 | 19% | 2.55 | 102 / 527 |
stomach | 45% | 2729.55 | 160 / 359 | 27% | 2.77 | 76 / 286 |
muscle | 38% | 1600.78 | 303 / 803 | 0% | 0 | 0 / 0 |
heart | 27% | 1261.09 | 233 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 22% | 1.19 | 10 / 45 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.78 | 5 / 29 |
brain | 0% | 2.12 | 2 / 2642 | 15% | 1.14 | 106 / 705 |
spleen | 10% | 447.24 | 24 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 17.81 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0006629 | Biological process | lipid metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0070062 | Cellular component | extracellular exosome |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0071949 | Molecular function | FAD binding |
GO_0051287 | Molecular function | NAD binding |
GO_0051537 | Molecular function | 2 iron, 2 sulfur cluster binding |
GO_0005506 | Molecular function | iron ion binding |
GO_0043546 | Molecular function | molybdopterin cofactor binding |
GO_0004031 | Molecular function | aldehyde oxidase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
Gene name | AOX1 |
Protein name | aldehyde oxidase (EC 1.2.3.1) Aldehyde oxidase 1 Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-) |
Synonyms | AO |
Description | FUNCTION: Oxidase with broad substrate specificity, oxidizing aromatic azaheterocycles, such as N1-methylnicotinamide, N-methylphthalazinium and phthalazine, as well as aldehydes, such as benzaldehyde, retinal, pyridoxal, and vanillin. Plays a key role in the metabolism of xenobiotics and drugs containing aromatic azaheterocyclic substituents. Participates in the bioactivation of prodrugs such as famciclovir, catalyzing the oxidation step from 6-deoxypenciclovir to penciclovir, which is a potent antiviral agent. Is probably involved in the regulation of reactive oxygen species homeostasis. May be a prominent source of superoxide generation via the one-electron reduction of molecular oxygen. May also catalyze nitric oxide (NO) production via the reduction of nitrite to NO with NADH or aldehyde as electron donor. May play a role in adipogenesis. . |
Accessions | ENST00000454629.1 ENST00000260930.10 H7C3Q1 H7BXF7 ENST00000439380.1 Q06278 ENST00000374700.7 C9J244 A0A286LWX1 |